| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 15.42 CHF | -0.05 CHF | -0.32 % |
|---|
| Vortag | 15.47 CHF | Datum | 24.01.2025 |
Franklin Biotechnology Discovery Fund A(acc)CHF-H1 Fonds Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 498.84% | |
| 21Shares Stellar ETP | CH1109575535 | 355.41% | |
| 21Shares Algorand ETP | CH1146882316 | 235.30% | |
| 21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
| 21Shares Cardano ETP | CH1102728750 | 186.31% | |
| 21Shares Sui Staking ETP | CH1360612159 | 127.75% | |
| 21Shares Injective Staking ETP | CH1360612134 | 4.24% | |
| 21Shares Immutable ETP | CH1360612142 | -16.58% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Sui Staking ETP | CH1360612159 | 429.14% | |
| 21Shares Ripple XRP ETP | CH0454664043 | 404.78% | |
| 21Shares Stellar ETP | CH1109575535 | 328.07% | |
| 21Shares Aave ETP | CH1135202120 | 262.56% | |
| 21Shares Algorand ETP | CH1146882316 | 196.87% | |
| 21Shares Cardano ETP | CH1102728750 | 148.81% | |
| 21Shares Injective Staking ETP | CH1360612134 | -18.81% | |
| 21Shares Immutable ETP | CH1360612142 | -24.14% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 509.08% | |
| 21Shares Aave ETP | CH1135202120 | 288.41% | |
| 21Shares Stellar ETP | CH1109575535 | 286.15% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 257.17% | |
| 21Shares Solana staking ETP | CH1114873776 | 210.63% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Solana staking ETP | CH1114873776 | 1’066.36% | |
| 21Shares Ripple XRP ETP | CH0454664043 | 644.02% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 388.24% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 366.94% | |
| 21Shares Stellar ETP | CH1109575535 | 366.51% |
Fundamentaldaten
| Valor | 22043741 |
| ISIN | LU0959058974 |
| Emittent | Franklin Templeton International Services |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 16.08.2013 |
| Kategorie | Branchen: Andere Sektoren |
| Währung | CHF |
| Volumen | 1’251’440’415.19 |
| Depotbank | J.P. Morgan SE, Luxembourg Branch |
| Geschäftsjahresende | 30.06. |
| Berichtsstand | 22.01.2025 |
Anlagepolitik
So investiert der Franklin Biotechnology Discovery Fund A(acc)CHF-H1 Fonds: Anlageziel dieses Fonds ist das Kapitalwachstum.
Der Fonds investiert in erster Linie in Beteiligungspapiere von Biotech- und
Forschungsunternehmen in den USA und anderen Ländern und in geringerem Maße in Schuldtitel jeglicher Art von Emittenten rund um den Globus.
ETP Performance: Franklin Biotechnology Discovery Fund A(acc)CHF-H1 Fonds
| Performance 1 Jahr | -3.02 | |
| Performance 2 Jahre | 7.68 | |
| Performance 3 Jahre | 8.52 | |
| Performance 5 Jahre | 0.39 | |
| Performance 10 Jahre | -7.05 |